Literature DB >> 12682330

Neuropathological findings in Sneddon's syndrome.

David A Hilton1, David Footitt.   

Abstract

The authors report the neuropathologic findings in a case of Sneddon's syndrome. There were multiple small, predominantly cortical, infarcts, with focal hyperplasia and fibrotic occlusion of arterial vessels in the superficial white matter, cortex, and leptomeninges. A very occasional arterial thrombus was seen. These findings suggest that Sneddon's syndrome is caused by a noninflammatory arteriopathy affecting superficial cerebral vessels.

Entities:  

Mesh:

Year:  2003        PMID: 12682330     DOI: 10.1212/01.wnl.0000055931.66009.d3

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Sneddon syndrome and non-bacterial thrombotic endocarditis: a clinicopathological study.

Authors:  José Berciano; Nuria Terán-Villagrá
Journal:  J Neurol       Date:  2018-07-06       Impact factor: 4.849

2.  Livedo and ischemic strokes: diagnostic hints of a rare condition.

Authors:  Giovanni Cirillo; Alessandro Tessitore; Mario Cirillo; Fabrizio Salemi; Sara Liguori; Sabrina Esposito; Gioacchino Tedeschi
Journal:  Neurol Sci       Date:  2013-05-10       Impact factor: 3.307

Review 3.  Heritable and non-heritable uncommon causes of stroke.

Authors:  A Bersano; M Kraemer; A Burlina; M Mancuso; J Finsterer; S Sacco; C Salvarani; L Caputi; H Chabriat; S Lesnik Oberstein; A Federico; E Tournier Lasserve; D Hunt; M Dichgans; M Arnold; S Debette; H S Markus
Journal:  J Neurol       Date:  2020-04-21       Impact factor: 4.849

4.  Miscarriage, peripheral thromboses and aortic aneurysm in antiphospholipid-antibody-negative Sneddon's syndrome.

Authors:  Markus Kraemer; Martin W Baumgaertel; Peter Berlit
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 6.682

Review 5.  Sneddon's syndrome: a comprehensive review of the literature.

Authors:  Shengjun Wu; Ziqi Xu; Hui Liang
Journal:  Orphanet J Rare Dis       Date:  2014-12-31       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.